An open-label, first-in-human study of SKB500 in patients with locally advanced or metastatic solid tumors.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Jilin Province Tumor Hospital, Jiangsu Province Hospital, Sheng Jing Hospital, China Medical University, Chengdu Fifth People's Hospital, Zhengzhou University, Henan Cancer Hospital, Henan University of Science and Technology, First Affiliated Hospital of Henan University of Science and Technology, First Affiliated Hospital of Zhengzhou University, Shanghai Pulmonary Hospital, Jiangxi Provincial Cancer Hospital, Second Affiliated Hospital of Nanchang University, First Affiliated Hospital of Xinxiang Medical University, Hunan Cancer Hospital, Third Affiliated Hospital of Harbin Medical University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Liaoning Cancer Hospital & Institute, Fujian Provincial Cancer Hospital, Kelun Group (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162543063